YAMAMOTO LAB

National Cerebral and Cardiovascular Center

News

2023/05/10

New Publication in Communications Biology by Dr. Yamamoto, Dr. Choi and Mr. Matoba "The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice"

2022/05/18

Our website is now open!